Merck to Deliver 3.1 Million Treatment Courses of COVID Antiviral

In June, the US government agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and in November agreed to buy an additional 1.4 billion courses for $1 billion.
WebMD Health News

source https://www.medscape.com/viewarticle/967896?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost